{
    "code": "02018613",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02018613",
    "time": "2020-02-25 11:56:13",
    "許可證字號": "衛署藥輸字第018613號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "110\/05\/23",
    "發證日期": "105\/05\/23",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00201861307",
    "中文品名": "&quot;速溶&quot; 艾黴素注射劑５０公絲",
    "英文品名": "ADRIBLASTINA RAPID DISSOLUTION 50MG",
    "適應症": "急慢性白血球過多症、硬瘤、淋巴瘤、軟纖維性肉瘤、交感神經母細胞瘤、乳癌、肺癌。",
    "劑型": "243凍晶注射劑",
    "包裝": "50公絲小瓶裝 100支以下盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": [
        ""
    ],
    "藥品類別": "05限由醫師使用",
    "藥品分類": "",
    "主製造廠": {
        "限制項目": "02輸　入",
        "申請商名稱": "1504401100  輝瑞大藥廠股份有限公司",
        "申請商地址": "新北市淡水區中正東路二段１７７號",
        "主製造廠": ""
    },
    "CCC號列": "30049071005 抗癌藥Anti-cancer preparations",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1003000610",
            "成分名稱": "DOXORUBICIN HCL",
            "含量描述": "",
            "含量": "50.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "Adriblastina Rapid Dissolution 50mg 藥輸018613-103-04-21.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02018613&Seq=001&Type=9"
        }
    ]
}